1201 ORANGE STREET, WILMINGTON, DE
News, Material Contracts
Annual Report to Security Holders
News, Legal Opinion
Announces Path to New Drug Application with Real World Data and Broader Proposed Indication for NRX-100 (ketamine) Following Type C FDA Meeting.
Appointment of Jonathan Javitt as Chief Operating Officer
Announces 2025 Annual Meeting Date and Record Date
Announces Debt Cancellation Agreement
News, Letter Re Change in Certifying Accountant
Q3
Q2
Notice of Late Filing for Quarterly Report
Q1
Amended Annual Report
FY 2024
Prospectus filed pursuant to Rule 424(b)(5)
Prospectus filed pursuant to Rule 424(b)(3)
Effectiveness Notice
Amended Registration Statement for Securities Offered under a Shelf Registration
RW
Registration Statement for Securities Offered under a Shelf Registration
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Initial Statement of Beneficial Ownership
Statement of Changes in Beneficial Ownership
Prospectus filed pursuant to Rule 424(b)(7)
Correspondence
Submission Upload
Post-Effective Amendment to Registration Statement